NFKB1 and acute respiratory distress syndrome: CIP2A is also a major regulator of immune responses, especially nuclear factor kappa B (NFκB) and cytokine pathways [4,12], which could make it relevant in diseases such as pneumonia, acute lung injury (ALI), and acute respiratory distress syndrome (ARDS).